Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc (BHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bausch Health Companies Inc 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8 CAN

www.bauschhealth.com Employees: 20,700 P: 514-744-6792 F: 514-744-0646

Sector:

Medical

Description:

Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.

Key Statistics

Overview:

Market Capitalization, $K 2,662,746
Enterprise Value, $K 23,077,746
Shares Outstanding, K 370,856
Annual Sales, $ 9,625 M
Annual Net Income, $ -46,000 K
Last Quarter Sales, $ 2,681 M
Last Quarter Net Income, $ 179,000 K
EBIT, $ 2,945 M
EBITDA, $ 4,349 M
60-Month Beta 0.41
% of Insider Shareholders 19.97%
% of Institutional Shareholders 78.65%
Float, K 296,796
% Float 80.03%
Short Interest 5,649
Short Float 1.52%
Short Volume Ratio 0.29

Growth:

1-Year Return -5.39%
3-Year Return 14.33%
5-Year Return -65.48%
5-Year Revenue Growth 11.91%
5-Year Earnings Growth -10.61%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.16 on 10/29/25
Next Earnings Date 02/18/26
Earnings Per Share ttm 3.80
EPS Growth vs. Prev Qtr 28.89%
EPS Growth vs. Prev Year 3.57%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 1.000 on 11/10/10
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 10/16/00

BHC Ratios

Ratio
Price/Earnings ttm 1.93
Price/Earnings forward 1.90
Price/Earnings to Growth N/A
Return-on-Equity % -9,620.34%
Return-on-Assets % 5.30%
Profit Margin % -0.48%
Debt/Equity 59.11
Price/Sales 0.28
Price/Cash Flow 0.95
Price/Book 7.62
Book Value/Share 0.96
Interest Coverage -1.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar